Hepatology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hepatology

Filter
EMJ
4 Feb 2015

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…
EMJ
12 Jan 2015

Artificial Liver Leads the Way as New Life-Saver

BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or…
EMJ
6 Jan 2015

Liver Cancer Menace May Lie in Surrounding Immunity

MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells…
EMJ
6 Jan 2015

Gene Culprit behind Metabolic Syndrome Revealed

HEALTHY gut microbiota may be the key to tackling metabolic syndrome (MetS); when a particular gene, known as Toll-like receptor 5 (TLR5), is…
EMJ
25 Nov 2014

Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer

Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)
We’ve noticed you’re accessing
from North/South America.